Company / Interest Expense
Phio Pharmaceuticals Corp. Interest Expense History
FY2012-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-$30.0K
FY2013
5-year range
-
FY2012-FY2013
Trend
-105.0%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
-$30,000 in FY2013.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, interest expense decreased 105.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.94 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2013 | -$30.0K | -105.0% |
| FY2012 | $598.0K | - |
As of FY2013 · SEC 10-K · Updated Jun 28, 2026